Therapeutic Drug Monitoring of Lacosamide: Is 10 to 20 mg/L a Suitable Reference Range for Patients With Epilepsy?-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring of Lacosamide: Is 10 to 20 mg/L a Suitable Reference Range for Patients With Epilepsy?

Published:2022-12-27 Issue:2 Volume:46 Page:39-42
ISSN:1537-162X
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:Clin Neuropharm

Author:

Otero Torres Sara,Juvany Roig Roser,Falip Centellas Mercè,Casellas Gibert Miriam,Estopiñá Antolí Mónica,Rigo Bonnin Raül,Sala-Padro Jacint Xavier,Jódar Massanés Ramón

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference9 articles.

1. A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy;Ther Drug Monit,2010

2. Therapeutic Drug monitoring of lacosamide in Norway: focus on pharmacokinetic variability, efficacy and tolerability;Neurochem Res,2017

3. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update;Ther Grup Monit,2018

4. Establishment of expected ranges for the random serum concentration of lacosamide and desmethyl lacosamide;Clin Chem,2014

5. Intravenous lacosamide in status epilepticus: correlation between loading dose, serum levels, and clinical response;Epilepsy Res,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of lacosamide and mirtazapine self-poisoning;Legal Medicine;2024-07

2. Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with epilepsy: A real-world observation study;Biomedical Journal;2023-11